Stock Information
Organogenesis Holdings Inc (ORGO)
Ticker Symbol: ORGO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $407.39 mil
Piotroski score: 7
PE Ratio: 8.2676
EPS (TTM): 0.2516
Revenue (TTM): $4.00 M
Dividend Yield: N/A%
ROE: 9.56%
Latest News
-
What's Going On With Organogenesis Stock On Wednesday?
Wed, Apr 8, 2026 10:15 AM
-
Organogenesis: Clinical Win De-Risks 2026, Recovery In Sight
Tue, Apr 7, 2026 1:01 PM
-
Organogenesis Stock Rockets After Diabetic Foot Ulcer Trial Posts Statistically Significant Win
Tue, Apr 7, 2026 8:22 AM
-
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tue, Apr 7, 2026 8:05 AM
-
Organogenesis shares are trading higher after the company announced that its trial evaluating PuraPlyAM plus standard of care achieved its primary endpoint, demonstrating statistically significant wound closure at 12 weeks.
Tue, Apr 7, 2026 7:47 AM
-
Why Silo Pharma Shares Are Trading Higher By Around 52%; Here Are 20 Stocks Moving Premarket
Tue, Apr 7, 2026 5:20 AM
-
Reported Earlier, Organogenesis Reports PuraPly AM Meets Primary Endpoint In Randomized Controlled Trial, Demonstrating Statistically Significant DFU Wound Closure At 12 Weeks
Tue, Apr 7, 2026 2:03 AM
-
Organogenesis Holdings Completes Type-B Meeting With FDA And Plans to File BLA For ReNu Before The End Of December
Mon, Apr 6, 2026 5:37 PM
Key Financials
Financial data not available
